Fresh off first sickle cell drug approval, Global Blood strikes new deals

In the wake of its FDA nod, the South City company has lined up a $150 million loan agreement and, separately, a potential $375 million partnership with Syros Pharmaceuticals.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news